Hongjuan Niu

机构：Minzu University of China

发表论文 7 篇 · 总被引 108 次 · h-index 5

代表论文

• Comprehensive pan-cancer analysis on CBX3 as a prognostic and immunological biomarker (2022 · BMC Medical Genomics · 被引 36)
• Functional and binding studies of gallic acid showing platelet aggregation inhibitory effect as a thrombin inhibitor (2021 · Chinese Herbal Medicines · 被引 27)
• Bioactivity-guided separation of potential α-glycosidase inhibitor from clerodendranthus spicatus based on HSCCC coupled with molecular docking (2021 · Scientific Reports · 被引 21)
• Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway (2022 · Biomedicine & Pharmacotherapy · 被引 14)
• The therapeutic mechanism of PuRenDan for the treatment of diabetic nephropathy: Network pharmacology and experimental verification (2022 · Journal of Ethnopharmacology · 被引 9)
• Comprehensive Pan-Cancer Analysis on CBX3 as a Prognostic and Immunological Biomarker (2021 · Research Square · 被引 1)